We utilize the whole genome to provide clinically actionable insights and guide health decisions throughout a patient's life — combining genomic sequencing and industry-leading risk scoring with a platform that's easy to integrate with routine care.
Whole genome
sequenced, not a fixed panel
One sample
blood or buccal, re-queried over time
Integrated Risk
genetics plus clinical risk factors
Counseling
included with every result
Rather than limiting our genetic sequencing to a small selection of coding regions, MyOme sequences the whole genome. That means we can provide better clinical utility, with insights for common conditions alongside rare, single-gene diseases.
It also allows us to use one sample to provide access to an expanding menu of tests, and even re-query a patient's genome as healthcare needs change and new information about genomics is discovered.
A clinical-grade test that sequences the entire genome at an average depth of 30 reads per base, ensuring high accuracy and reliability. As the gold standard in genetic testing, it enables comprehensive detection of SNVs, indels, structural variants, and copy number changes — supporting diagnosis, risk assessment, and treatment decisions with a more complete view than targeted tests.
BGE combines low-pass whole-genome sequencing with deeper-coverage whole-exome sequencing, allowing high quality imputation of common variants across the genome as well as detection of rare coding variants across the exome region — all from a single sequence.
We integrate clinical risk factors with millions of genetic variants that confer risk for common health conditions — providing a more accurate assessment of patient risk than either source can provide alone.
We adjust for differences in genetics due to ancestry and use continuous ancestry decomposition to account for admixture in individuals. That information is integrated with the patient's risk based on clinical measures — such as the Tyrer-Cuzick model for breast cancer or the ASCVD Pooled Cohort Equations for coronary artery disease. The result is a unique, holistic, clinically relevant report.
Common clinical risk calculators and values
Polygenic Risk Scores from the whole genome
Unique, Holistic Clinically Relevant Reports
Proprietary ad-mixed approach eliminates self-reporting of ancestry
Focused on data safety, confidentiality and integrity
Our process was designed to be customizable and easy to implement. Ordering is simple through our provider portal, with kits available for buccal or blood collection.
01Providers order through the MyOme portal in a few clicks.
02Kits are available for buccal or blood collection.
03We sequence the genome and run analysis in our CLIA-certified, CAP-accredited lab.
04A report with actionable clinical insights, with options for independent provider review and a patient-friendly note.
Genetic testing is more than a report. We offer complimentary access to genetic counseling from an independent provider, connecting patients with the support they need to understand their results and make the healthcare decisions that are right for them.
